DIFFERENT BEHAVIOR OF MOUSE-HUMAN CHIMERIC ANTIBODY F(AB')2 FRAGMENTS OF IGG1, IGG2 AND IGG4 SUBCLASS INVIVO

被引:27
作者
BUCHEGGER, F
PELEGRIN, A
HARDMAN, N
HEUSSER, C
LUKAS, J
DOLCI, W
MACH, JP
机构
[1] CIBA GEIGY AG,BIOTECHNOL SECT,CH-4002 BASEL,SWITZERLAND
[2] CIBA GEIGY AG,IMMUNOL SECT,CH-4002 BASEL,SWITZERLAND
关键词
D O I
10.1002/ijc.2910500316
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mouse-human chimeric monoclonal antibodies (MAbs) of 3 different human IgG sub-classes directed against carcinoembryonic antigen (CEA) have been produced in SP-0 cells transfected with genomic chimeric DNA. F(ab')2 fragments were obtained by pepsin digestion of the purified chimeric MAbs of human IgG1, IgG2 and IgG4 sub-class and of parental mouse MAb IgG1. The 4 F(ab')2 fragments exhibit similar molecular weight by SDS-PAGE. They were labelled with I-125 or I-131 and high binding (80 to 87%) to purified unsolubilized CEA was observed. In vivo, double labelling experiments indicate that the longest biological half-life and the highest tumour-localization capacity is obtained with F(ab')2 from chimeric MAb of human IgG2 sub-class, whereas F(ab')2 from chimeric MAb IgG4 give very low values for these 2 parameters. F(ab')2 from chimeric MAb IgG1 and from parental mouse MAb yield intermediate results in vivo. Our findings should help to select the appropriate human IgG sub-class to produce chimeric or reshaped MAb F(ab')2 to be used for tumour detection by immunoscintigraphy and for radioimmunotherapy.
引用
收藏
页码:416 / 422
页数:7
相关论文
共 31 条
  • [1] BISCHOFDELALOYE A, 1989, J NUCL MED, V30, P1646
  • [2] COMPARISON OF THERAPEUTIC EFFICACY AND HOST TOXICITY OF 2 DIFFERENT I-131-LABELLED ANTIBODIES AND THEIR FRAGMENTS IN THE GW-39 COLONIC-CANCER XENOGRAFT MODEL
    BLUMENTHAL, RD
    SHARKEY, RM
    KASHI, R
    GOLDENBERG, DM
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (02) : 292 - 300
  • [3] ABLATION OF HUMAN-COLON CARCINOMA IN NUDE-MICE BY I-131-LABELED MONOCLONAL ANTI-CARCINOEMBRYONIC ANTIGEN-ANTIBODY F(AB')2 FRAGMENTS
    BUCHEGGER, F
    PFISTER, C
    FOURNIER, K
    PREVEL, F
    SCHREYER, M
    CARREL, S
    MACH, JP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (05) : 1449 - 1456
  • [4] BUCHEGGER F, 1983, J EXP MED, V158, P413, DOI 10.1084/jem.158.2.413
  • [5] BUCHEGGER F, 1986, CANCER, V58, P655, DOI 10.1002/1097-0142(19860801)58:3<655::AID-CNCR2820580310>3.0.CO
  • [6] 2-E
  • [7] BUCHEGGER F, 1990, J NUCL MED, V31, P1035
  • [8] COLCHER D, 1983, CANCER RES, V43, P736
  • [9] INVIVO TUMOR TARGETING OF A RECOMBINANT SINGLE-CHAIN ANTIGEN-BINDING PROTEIN
    COLCHER, D
    BIRD, R
    ROSELLI, M
    HARDMAN, KD
    JOHNSON, S
    POPE, S
    DODD, SW
    PANTOLIANO, MW
    MILENIC, DE
    SCHLOM, J
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (14): : 1191 - 1197
  • [10] COLCHER D, 1989, CANCER RES, V49, P1738